Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Amici Procurement Solutions

Amici provide cutting edge sourcing solutions to companies across the Biotech industry. Our business is to deliver greater savings through improved supplier performance. We can support you whether you are looking for an outsourced procurement resource or simply to save money quickly. We offer consortium deals, consultancy, training and a virtual purchasing resource. Uniquely, we also provide a savings guarantee.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs

- PMLiVE

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Advertising, Branding, Creative and design, Digital communications, Management consultancies, Marketing consultancies, Media planning and buying, Medical communications, Medical education, Patient support and adherence, Public relations

- PMLiVE

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

Branding, Creative and design, Management consultancies, Market access, Market research, Media planning and buying, Medical communications, Medical education, Public relations

OPEN Health

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Medical education, Patient support and adherence, Public relations, Training

Sciterion Logo

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs

Company Details

Amici Procurement Solutions
3 Centura Court, Nasmyth Place, Glasgow, G52 4PR
+44 (0)141 810 2580
Contact Amici Procurement Solutions
Website

 Latest Content from PMHub 

Adding different perspectives to scientific communications at Porterhouse Medical

Press Releases | April 17, 2019 | Porterhouse Medical Group

Porterhouse Medical Group is delighted to announce that, once again, we have strengthened our scientific services team – this time with three new associate medical writers who, with different scientific...

Cuttsy+Cuttsy awarded CPD Platinum by the IPA

White Papers and Resources | April 16, 2019 | Cuttsy + Cuttsy

Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation.

The playbook of a ‘reluctant creative’

Press Releases | April 10, 2019 | Bedrock Healthcare Communications

Are we all capable of being creative?

Clinical Trials Materials: Getting the Basics Right

White Papers and Resources | April 9, 2019 | Cuttsy + Cuttsy

For those unfamiliar with them, clinical trials can be rather bewildering. This presents problems when it comes to recruiting patients — how can we make sure they understand what they...

News: Research Partnership is listed in the Alantra Pharma Fast 50 annual report

White Papers and Resources | April 9, 2019 | Inizio

The best performing privately-owned UK pharmaceutical businesses were revealed earlier this month with the publication of Pharma Times’ Alantra Pharma Fast 50 annual report.Read more about this report here

Event: Blending data science and market research at the Data Analytics & Insight conference

White Papers and Resources | April 9, 2019 | Inizio

Last month Analytics Director Misti Paul attended the Data Analytics & Insight Conference. In our latest blog post she reflects on the presentations that were given and what lessons can be...

Presentation: Optimize your digital assets with UX research

White Papers and Resources | April 9, 2019 | Inizio

US Director Liza Pliss recently presented the paper 'Optimize your digital assets with UX research' at the PMR Conference in New Jersey, USA. Don't worry if you missed it though,...

Report: Living With Rheumatoid Arthritis 2019 reports now available to purchase

White Papers and Resources | April 9, 2019 | Inizio

We have published new Living with Rheumatoid Arthritis reports in 5EU, Japan and Canada. The reports consist of 30-minute quantitative online and qualitative telephone interviews with RA patients. Read more on...

Infographic: Rheumatoid arthritis (RA)

White Papers and Resources | April 9, 2019 | Inizio

An overview of the RA biologic patientOur RA market snapshot offers an introduction to the real world patient data collected by our Therapy Watch RA study. The snapshot looks at...

Webcast: Navigating new frontiers: Ways to find space in the future RA market

White Papers and Resources | April 9, 2019 | Inizio

In partnership with pharmaphorumView the webcast »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors, are shaking up a once-stable market.Although there are only...